Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Barberis

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Pathologica|January 3, 2025
BRCA testing in metastatic castration-resistant prostate cancer: successes and troubles in a real world setting. An Italian Multicentric studyStefania Tommasi, Claudio Antonio Coppola, Alessandro Caniglia, et al.
BMC Cancer|April 3, 2022
Single fraction ablative preoperative radiation treatment for early-stage breast cancer: the CRYSTAL study - a phase I/II clinical trial protocolMaria Alessia Zerella, Mattia Zaffaroni, Giuseppe Ronci, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2024
Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnosticsStanislas Quesada, Frédérique Penault-Llorca, Xavier Matias-Guiu, et al.
JAMA Network Open|April 23, 2024
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer PhenotypeGiovanni Corso, Elena Marino, Cristina Zanzottera, et al.
Diagnostics (Basel, Switzerland)|October 12, 2019
<i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic LaboratoriesEttore Capoluongo, Nicla La Verde, Massimo Barberis, et al.
Critical Reviews in Oncology/Hematology|June 9, 2019
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relativesStefania Gori, Massimo Barberis, Maria Angela Bella, et al.
Journal of Clinical Pathology|August 2, 2020
Predictive molecular pathology in the time of coronavirus disease (COVID-19) in EuropeUmberto Malapelle, Pasquale Pisapia, Antonino Iaccarino, et al.
Journal of Clinical Pathology|March 26, 2021
TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation studyUmberto Malapelle, Francesco Pepe, Pasquale Pisapia, et al.
Cell Host & Microbe|October 31, 2024
Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patientsAngeli D G Macandog, Carlotta Catozzi, Mariaelena Capone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2020
Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE TrialElena Guerini-Rocco, Kathryn P Gray, Caterina Fumagalli, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Pathologica|January 3, 2025
BRCA testing in metastatic castration-resistant prostate cancer: successes and troubles in a real world setting. An Italian Multicentric studyStefania Tommasi, Claudio Antonio Coppola, Alessandro Caniglia, et al.
BMC Cancer|April 3, 2022
Single fraction ablative preoperative radiation treatment for early-stage breast cancer: the CRYSTAL study - a phase I/II clinical trial protocolMaria Alessia Zerella, Mattia Zaffaroni, Giuseppe Ronci, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2024
Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnosticsStanislas Quesada, Frédérique Penault-Llorca, Xavier Matias-Guiu, et al.
JAMA Network Open|April 23, 2024
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer PhenotypeGiovanni Corso, Elena Marino, Cristina Zanzottera, et al.
Diagnostics (Basel, Switzerland)|October 12, 2019
<i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic LaboratoriesEttore Capoluongo, Nicla La Verde, Massimo Barberis, et al.
Critical Reviews in Oncology/Hematology|June 9, 2019
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relativesStefania Gori, Massimo Barberis, Maria Angela Bella, et al.
Journal of Clinical Pathology|August 2, 2020
Predictive molecular pathology in the time of coronavirus disease (COVID-19) in EuropeUmberto Malapelle, Pasquale Pisapia, Antonino Iaccarino, et al.
Journal of Clinical Pathology|March 26, 2021
TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation studyUmberto Malapelle, Francesco Pepe, Pasquale Pisapia, et al.
Cell Host & Microbe|October 31, 2024
Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patientsAngeli D G Macandog, Carlotta Catozzi, Mariaelena Capone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2020
Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE TrialElena Guerini-Rocco, Kathryn P Gray, Caterina Fumagalli, et al.
Pageof 17